Copyright
©The Author(s) 1997.
World J Gastroenterol. Dec 15, 1997; 3(4): 238-241
Published online Dec 15, 1997. doi: 10.3748/wjg.v3.i4.238
Published online Dec 15, 1997. doi: 10.3748/wjg.v3.i4.238
Table 4 Anti-tumor effect in Group A and B patients
| Group | A | B |
| Partial response (%) | 0 (0) | 8 (17.4) |
| No change (moderate response) | 16 (1) | 17 (2) |
| Progressive lesion | 31 | 21 |
| 95% reliability | 0, 6.2% | 6.4%, 28.4% |
| Fisher’s test | P > 0.01 | P > 0.01 |
| Median survival time | 108 d | 112 d |
| Average course | 1.9 | 2.3 |
- Citation: Xiao SD, Li DH, Zhang DZ, Shen MJ, Zhu XT, He GF, Zhao TP, Li LP, Deng XC, Wang M, Wang XL, Chen Q, Zhang YP, Yao CL, Bao JG, Tong GW, Zhu LF, Jiang H, Minoru K. Multicenter randomized study on Me-CCNU, 5-FU and ADM vs ACNU, 5-FU and ADM for treatment of advanced gastric cancer. World J Gastroenterol 1997; 3(4): 238-241
- URL: https://www.wjgnet.com/1007-9327/full/v3/i4/238.htm
- DOI: https://dx.doi.org/10.3748/wjg.v3.i4.238